SNCA and Parkinson disease: Targeting Nedd4-mediated ubiquitination of α-synuclein is a promising therapeutic strategy for mitigating Parkinsons disease and other α-synucleinopathies (Eller and Williams 2011; Altay et al. 2022; Lashuel et al. 2022).